eli lilly and tirzepatide weight loss drug data released Tirzepatide Tops Semaglutide for Weight

The primary concerns include enhanced gastrointestinal side effects (nausea, vomiting) due to overlapping effects on gastric emptying, potential difficulty meeting protein requirements, dehydration risk, and nutritional deficiencies

Safety - May be safer than other options due to its unique mechanism

In this period, reaching both hands over your head may be tough

In Philadelphia and Pittsburgh, many practices have limited availability for new weight management consultations given the volume of demand relative to provider supply

Hypothyroidism affects approximately 5% of the U.S

Tirzepatide represented the second generation of this research, introducing a unimolecular dual agonist approach